Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-017130
Filing Date
2025-10-06
Accepted
2025-10-06 17:30:02
Documents
1
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3334
  Complete submission text file 0001493152-25-017130.txt   5074
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
Q/C TECHNOLOGIES, INC. (Issuer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 902 N BROOM ST WILMINGTON DE 19806
Business Address
Glass Mitchell (Reporting) CIK: 0002023649 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36268 | Film No.: 251377749